Taken together, these data indicate that BRD9 can facilitate the binding of P300 to the TUFT1 promoter, which resulted in increased H3K27Ac, and thus leads to the increased expression level of TUFT1 in HCC cells. Here, TUFT1 is linked to hepatocellular carcinoma.